| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
|
J Nutr Biochem
|
2007
|
1.63
|
|
2
|
Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease.
|
J Pediatr Gastroenterol Nutr
|
2008
|
1.54
|
|
3
|
Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.
|
Am J Clin Nutr
|
2007
|
1.49
|
|
4
|
Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment.
|
PLoS One
|
2013
|
1.48
|
|
5
|
Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation.
|
J Am Coll Nutr
|
2004
|
1.33
|
|
6
|
Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
1.26
|
|
7
|
Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease.
|
J Pediatr
|
2005
|
1.19
|
|
8
|
Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury.
|
Am J Pathol
|
2011
|
1.14
|
|
9
|
Monocyte activation in alcoholic liver disease.
|
Alcohol
|
2002
|
1.11
|
|
10
|
Good fat/bad fat.
|
Hepatology
|
2007
|
1.10
|
|
11
|
Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
1.06
|
|
12
|
S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice.
|
J Nutr Biochem
|
2003
|
1.06
|
|
13
|
S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease.
|
Hepatology
|
2004
|
1.06
|
|
14
|
Role of the proteasome in ethanol-induced liver pathology.
|
Alcohol Clin Exp Res
|
2007
|
0.99
|
|
15
|
Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.
|
Alcohol Clin Exp Res
|
2005
|
0.97
|
|
16
|
Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkappaB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells.
|
Microbiology
|
2006
|
0.95
|
|
17
|
Ethanol inhibits lipid raft-mediated TCR signaling and IL-2 expression: potential mechanism of alcohol-induced immune suppression.
|
Alcohol Clin Exp Res
|
2011
|
0.95
|
|
18
|
Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress.
|
Toxicol Appl Pharmacol
|
2012
|
0.95
|
|
19
|
S-Adenosylmethionine, cytokines, and alcoholic liver disease.
|
Alcohol
|
2002
|
0.93
|
|
20
|
Histone modifications and alcohol-induced liver disease: are altered nutrients the missing link?
|
World J Gastroenterol
|
2011
|
0.92
|
|
21
|
Diagnosis and treatment of alcoholic liver disease and its complications.
|
Alcohol Res Health
|
2003
|
0.90
|
|
22
|
Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells.
|
Cell Res
|
2009
|
0.90
|
|
23
|
S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway.
|
J Pharmacol Exp Ther
|
2011
|
0.89
|
|
24
|
S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes.
|
Am J Physiol Gastrointest Liver Physiol
|
2003
|
0.89
|
|
25
|
Binge alcohol-induced microvesicular liver steatosis and injury are associated with down-regulation of hepatic Hdac 1, 7, 9, 10, 11 and up-regulation of Hdac 3.
|
Alcohol Clin Exp Res
|
2012
|
0.88
|
|
26
|
S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor.
|
Biochim Biophys Acta
|
2005
|
0.86
|
|
27
|
Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
|
J Pharmacol Exp Ther
|
2008
|
0.85
|
|
28
|
Binge ethanol-induced HDAC3 down-regulates Cpt1α expression leading to hepatic steatosis and injury.
|
Alcohol Clin Exp Res
|
2013
|
0.83
|
|
29
|
Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.
|
J Pharmacol Exp Ther
|
2013
|
0.83
|
|
30
|
Modulation of endotoxin stimulated interleukin-6 production in monocytes and Kupffer cells by S-adenosylmethionine (SAMe).
|
Cytokine
|
2004
|
0.83
|
|
31
|
Trace metals and the elderly.
|
Clin Geriatr Med
|
2002
|
0.80
|
|
32
|
Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.
|
Free Radic Biol Med
|
2009
|
0.79
|
|
33
|
Impact of altered methylation in cytokine signaling and proteasome function in alcohol and viral-mediated diseases.
|
Alcohol Clin Exp Res
|
2012
|
0.78
|
|
34
|
Alcoholic Hepatitis: Steroids vs. Pentoxifylline.
|
Curr Hepat Rep
|
2013
|
0.76
|
|
35
|
Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infections.
|
J Interferon Cytokine Res
|
2014
|
0.76
|